Authors
Latest:
Cardiovascular Disease Risk Management During COVID-19: In-Person vs Virtual VisitsThis article compares cardiovascular disease risk management in community clinics during the COVID-19 pandemic among patients for whom primary care was delivered mostly in person vs mostly virtually.
Latest:
ACO Contracting With Private and Public Payers: A Baseline Comparative AnalysisThe authors find 51% of accountable care organizations have private payer contracts, which are more likely than public contracts to include downside risk and upfront payments.
Latest:
Improving Medication Understanding Among Latinos Through Illustrated Medication ListsA randomized controlled trial found that plain-language, illustrated medication lists improved medication understanding among Latinos.
Latest:
Quality Measure Improvement Strategies for Elderly Patients With DiabetesThe authors discuss a simple strategy for payers to ensure more patients with type 2 diabetes achieve control of A1C.
Latest:
Burden of Alzheimer's Disease and Association With Negative Health OutcomesCommunity-based persons with Alzheimer’s disease have a higher risk of fractures, hospitalization, and various comorbidities than persons without the disease.
Latest:
Pattern of Statin Use Among 10 Cohorts of New Users From 1995 to 2004: A Register-Based Nationwide StudyOne-year persistence among new users of statins in Finland improved from 1995 to 1998, after which no substantial changes were observed up to 2004.
Latest:
Geographic Variation in Surgical Outcomes and Cost Between the United States and JapanCompared with Japan, the United States has substantially less geographic variation in surgical outcomes, but it has higher variation in cost.
Latest:
Discussion 6: Nextâ€Generation Genetic Sequencing in Oncology: Ready for Prime Time?Mr Klein leads another discussion with Michael Kolodjiez, MD, Lee N. Newcomer, MD, MHA, John L. Fox, MD, MHA, and Jerry Conway. The panel responds to whether there are gaps in targeted gene analyses. They also discuss other issues including bioinformatics, and how payers, providers, and pharmacists might collaborate on improving care through genetic sequencing.
Latest:
Healthcare Network Analysis of Patients With Diabetes and Their PhysiciansNetwork analyses of patients with diabetes in Hawaii illustrate structures and links that health plans could leverage to strengthen quality improvement and disease management programs.
Latest:
Benzodiazepine and Unhealthy Alcohol Use Among Adult OutpatientsAmong outpatients who were screened for alcohol use, those with unhealthy alcohol use, women, and those who were older, white, and of lower socioeconomic status were more likely to use benzodiazepines.
Latest:
Adherence to Statins and LDL-Cholesterol Goal AttainmentThis study examined adherence to statins and low-density lipoprotein cholesterol goal attainment in patients with coronary artery disease.
Latest:
Prescription Opioid Abuse: Challenges and Opportunities for PayersThis article outlines strategies insurers can use to mitigate their risks related to prescription opioid abuse by members, while addressing this serious public health problem.
Latest:
Addressing Cancer Health Disparities in a Multilateral Collaboration in an Independent Community Cancer Clinic: Translating Words Into ActionNo One Left Behind, a program to provide financial assistance and access to cancer care at Carolina Blood and Cancer Care Associates in South Carolina, will be discussed during a session of the Community Oncology Alliance 2022 Community Oncology Conference.
Latest:
VA Geriatric Scholars Program’s Impact on Prescribing Potentially Inappropriate MedicationsPrimary care teams reduced their prescribing of potentially inappropriate medications to older veterans after participation in the Veterans Affairs (VA) Geriatric Scholars Program.
Latest:
Medical Policy Determinations for Pharmacogenetic Tests Among US Health PlansThis analysis demonstrated significant variability in medical policy determinations and evidence cited for clinically relevant pharmacogenetic tests among major US health insurers and laboratory benefit managers.
